Simon Read
Board Member
Dianthus Therapeutics, Inc. /DE/ (DNTH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Simon Read
Simon Read is recorded as Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH). Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed May 22, 2025 that Simon Read was appointed Class III director, effective May 22, 2025.
“On May 22, 2025, the Board appointed Simon Read, Ph.D., as a Class III director of the Company and as a member of both the Science and Technology Committee of the Board (the "S&T" Committee) and the Nominating and Corporate Governance Committee of the Board (the "N&CG" Committee), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-05-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Dianthus Therapeutics, Inc. /DE/
Other people whose current roles at this company are on record from its filings.
- Marino Garcia CEO, Board Member
- Alison F. Lawton Chairman
- Leon O. Moulder, Jr. Chairman, Board Member
- Ryan Savitz CFO, Board Member
- Steve Mahoney CFO
- Edward Carr Chief Accounting Officer, Board Member
- Adam Veness Board Member
- Anne McGeorge Board Member
- Jonathan Violin Board Member
- Jonathan Violin, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.